市場調査レポート

臓器保存ソリューション市場 - 世界の産業分析、規模、シェア、成長、動向および予測

Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 295919
出版日 ページ情報 英文 80 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
臓器保存ソリューション市場 - 世界の産業分析、規模、シェア、成長、動向および予測 Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年02月06日 ページ情報: 英文 80 Pages
概要

当レポートでは、臓器保存ソリューションの世界市場について世界規模および北米、欧州、アジア太平洋地域、その他の地域の地域別、ソリューション別および保存技術別にセグメント化し、2012年を基準として2011年から2019年までの売上市場規模を分析すると共に、前記セグメントごとに2013年から2019年までのCAGR(年平均成長率)を提供しております。また市場促進要因、制約要因および市場機会についてもお伝え致します。さらに2012年の地域別の市場魅力分析、世界市場に対するPorterのファイブフォース分析、主な企業の市場シェア、競合状況や主な企業のプロファイルを交えつつ、概略下記内容でお届け致します。

第1章 はじめに

  • レポートの説明
  • 市場のセグメンテーション
  • 調査方法

第2章 エグゼクティブサマリー

第3章 市場の概要

  • イントロダクション
  • 市場促進要因
    • 世界の人口高齢化
    • 技術の進歩
    • 増加する償還シナリオ
    • 1人当たりの医療支出の増加
  • 市場制約要因
    • 臓器提供者の不足
    • 高い手術費用
  • 市場機会
    • 顧客基盤の保持を確実にする研究指向の機関と医療機関との連携
  • 世界の臓器保存のソリューション市場に対するPorterのファイブフォース分析
    • 供給者の交渉力
    • 買い手の交渉力
    • 新規参入者の脅威
    • 代替品の脅威
    • 競合関係
  • 市場魅力分析:世界の臓器保存ソリューション市場、地域別

第4章 世界の臓器保存ソリューション市場、ソリューション別(百万米ドル)

  • 概要
  • Viaspan
  • Custodiol HTK-(ヒスチジン-トリプトファン-ケトグルタル) ソリューション
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • Human bioSystem (HBS)ソリューション
  • siRNA移植ソリューション
  • その他

第5章 世界の臓器保存ソリューション市場、保存技術別(百万米ドル)

  • 概要
  • 低体温灌流保存(HPP)
  • 静的コールドストレージ(SCS)
  • その他

第6章 世界の臓器保存ソリューション市場、地域別(百万米ドル)

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の地域(ROW)

第7章 競合状況

  • 主な企業別市場シェア(%)

第8章 提言

  • ヘルスケア・サービス・プロバイダーとの長期契約
  • 通網の幅を広げる
  • 製品の革新

第9章 企業プロファイル

  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • BioTime, Inc.
  • Bristol-Myers Squibb
  • Claris Lifesciences Limited
  • CryoLife, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Lifeline Scientific
  • Teva Pharmaceutical Industries Ltd.
  • ToleroTech, Inc.
  • XVIVO Perfusion AB
目次

Title: Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved, type of preservation techniques used and the major geographic markets. The global market for organ preservation solutions has been segmented into nine major solutions that include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). On the basis of preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques).

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for each solution type, technique type and geographic region. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. This section also covers a market attractiveness analysis (by geography) for the year 2012 and Porter's five forces analysis for the global organ preservation solutions market. Market share (%) for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. Also, the report includes company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

The global organ preservation solutions market has been segmented as below:

Organ Preservation Solutions Market, by Solution

  • Viaspan
  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • Human bioSystem (HBS) Solution
  • siRNA Transplant Solutions
  • Others

Organ Preservation Solutions Market, by Preservation Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others

Organ Preservation Solutions Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Aging global population
      • 3.2.1.1. Global rate of aging population
    • 3.2.2. Technological advancements
    • 3.2.3. Increasing reimbursement scenario
    • 3.2.4. Increase in per capita healthcare expenditure
  • 3.3. Market Restraints
    • 3.3.1. Lack of organ donors
      • 3.3.1.1. Widening Gap Between Patients Receiving Organ Transplants and Number of Donors in the U.S. (1998 - 2010)
    • 3.3.2. High cost of procedure
  • 3.4. Market Opportunities
    • 3.4.1. Collaboration with research-oriented organizations and medical institutes to ensure retention of customer base
  • 3.5. Porter's Five Force Analysis for the Global Organ Preservation Solutions Market
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat of substitutes
    • 3.5.4. Threat of new entrants
    • 3.5.5. Competitive rivalry
  • 3.6. Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

Chapter 4 - Global Organ Preservation Solutions Market, By Solution, 2011 - 2019 (USD Million)

  • 4.1. Overview
    • 4.1.1. Global Organ Preservation Solutions Market Revenue, by Solution Type, 2011 - 2019 (USD Million)
    • 4.1.2. Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)
  • 4.2. Viaspan
    • 4.2.1. Global Viaspan Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
    • 4.3.1. Global Custodiol Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Renograf
    • 4.4.1. Global Renograf Market Revenue, 2011 - 2019 (USD Million)
  • 4.5. Hypothermosol
    • 4.5.1. Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)
  • 4.6. Perfadex
    • 4.6.1. Global Perfadex Market Revenue, 2011 - 2019 (USD Million)
  • 4.7. Lifor
    • 4.7.1. Global Lifor Market Revenue, 2011 - 2019 (USD Million)
  • 4.8. Human bioSystem (HBS) Solution
    • 4.8.1. Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)
  • 4.9. siRNA Transplant Solution
    • 4.9.1. Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)
  • 4.10. Others
    • 4.10.1. Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Global Organ Preservation Solutions Market, By Preservation Technique, 2011 - 2019 (USD Million)

  • 5.1. Overview
    • 5.1.1. Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million)
    • 5.1.2. Comparative Analysis: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 & 2019 (Value %)
  • 5.2. Hypothermic Perfusion Preservation (HPP)
    • 5.2.1. Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 Static Cold Storage (SCS)
    • 5.3.1. Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)
  • 5.4. Others
    • 5.4.1. Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Global Organ Preservation Solutions Market, By Geography, 2011 - 2019 (USD Million)

  • 6.1. Overview
    • 6.1.1. Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million)
    • 6.1.2. Comparative Analysis: Global Organ Preservation Solutions Market, by Geography, 2012 & 2019 (Value %)
  • 6.2. North America
    • 6.2.1. North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Deceased Donation Rate (Per Million of Population), by Country, 2011
    • 6.3.2. Europe Organ Donation and Transplantation Data, 2011
    • 6.3.3. Donation and Transplantation Number Per European Country, 2011
    • 6.3.4. Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Organ Donation and Transplantation Data for Japan (2009 - 2013)
    • 6.4.2. Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Competitive Landscape

  • 7.1 Market Share by Key Players, 2012 (%)

Chapter 8 - Recommendations

  • 8.1. Long term contracts with healthcare service providers
  • 8.2. Broadening of distribution network
  • 8.3. Product innovation

Chapter 9 - Company Profiles

  • 9.1. 21st Century Medicine
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio
  • 9.2. BioLife Solutions, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategies
    • 9.2.5. Recent Developments
  • 9.3. BioTime, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategies
    • 9.3.5. Recent Developments
  • 9.4. Bristol-Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Overview
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategies
    • 9.4.5. Recent Developments
  • 9.5. Claris Lifesciences Limited
    • 9.5.1. Company Overview
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategies
    • 9.5.5. Recent Developments
  • 9.6. CryoLife, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Overview
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategies
    • 9.6.5. Recent Developments
  • 9.7. Dr. Franz Köhler Chemie GmbH
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Business Strategies
  • 9.8. Lifeline Scientific
    • 9.8.1. Company Profile
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategies
    • 9.8.5. Recent Developments
  • 9.9. Teva Pharmaceutical Industries Ltd.
    • 9.9.1. Company Profile
    • 9.9.2. Financial Overview
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategies
    • 9.9.5. Recent Developments
  • 9.10. ToleroTech, Inc.
    • 9.10.1. Company Profile
    • 9.10.2. Product Portfolio
    • 9.10.3. Business Strategies
  • 9.11. XVIVO Perfusion AB
    • 9.11.1. Company Overview
    • 9.11.2. Financial Overview
    • 9.11.3. Product Portfolio
    • 9.11.4. Business Strategies

List of Figures

  • FIG. 1: Organ Preservation Solutions Market Segmentation
  • FIG. 2: Global Organ Preservation Solutions Market, by Solution, 2012 (USD Million)
  • FIG. 3: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 (USD Million)
  • FIG. 4: Global Rate of Aging Population
  • FIG. 5: Gap Between Organ Transplant and Donors in the U.S. (1998 - 2010)
  • FIG. 6: Porter's Five Force Analysis: Global Organ Preservation Solutions Market
  • FIG. 7: Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography
  • FIG. 8: Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)
  • FIG. 9: Global Viaspan Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global Custodiol Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Global Renograf Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Global Perfadex Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: Global Lifor Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16: Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17: Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18: Comparative Analysis: Global Organ Preservation Solution Market, by Preservation Technique, 2012 & 2019 (Value %)
  • FIG. 19: Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20: Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21: Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22: Comparative Analysis: Global Organ Preservation Solution Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 23: North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24: Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25: Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 26: RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 27: Market Share by Key Players, 2012 (%)
  • FIG. 28: Annual Revenue: BioLife Solutions, Inc., 2010 - 2012 (USD Million)
  • FIG. 29: Annual Revenue: BioTime Inc., 2010 - 2012 (USD Million)
  • FIG. 30: Annual Revenue: Bristol-Myers Squibb, 2010 - 2012 (USD Million)
  • FIG. 31: Annual Sales: Claris Lifesciences Ltd., 2010 - 2012 (USD Million)
  • FIG. 32: Annual Revenue: CryoLife, Inc., 2010 - 2012 (USD Million)
  • FIG. 33: Annual Revenue: Lifeline Scientific, 2010 - 2012 (USD Million)
  • FIG. 34: Annual Revenue: Teva Pharmaceutical Industries Ltd., 2010 - 2012 (USD Million)
  • FIG. 35: Annual Sales: XVIVO Perfusion AB, 2010 - 2012 (USD Million)

List of Tables

TABLE 1: Market Snapshot: Global Organ Preservation Solutions Market TABLE 2: Global Organ Preservation Solutions Market Revenue, by Solution, 2011 - 2019 (USD Million) TABLE 3: Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million) TABLE 4: Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million) TABLE 5: Organ Donation and Transplantation Data for Japan (2009 - 2013)

Back to Top